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Background: Niemann-pick C1-like 1 (NPC1L1) is a key protein for intestinal cholesterol transportation. Common
single nucleotide polymorphisms (SNPs) in the NPC1L1 gene have been associated with cholesterol absorption and
serum lipid levels. The present study was undertaken to explore the possible association of NPC1L1 rs2072183
1735 C>G SNP and several environmental factors with serum lipid levels in the Mulao and Han populations.
Methods: Genotyping of the rs2072183 SNP was performed in 688 subjects of Mulao and 738 participants of Han
Chinese. The interactions between NPC1L1 1735 C>G polymorphism and several environmental factors on serum
lipid phenotypes were tested using the factorial design covariance analysis after controlling for potential
confounders.
Results: The frequency of G allele was lower in Mulao than in Han (29.72% vs. 37.26%, P< 0.001). The frequency of
CC, CG and GG genotypes was 49.85%, 40.84% and 9.31% in Mulao, and 39.30%, 46.88% and 13.82% in Han
(P< 0.001); respectively. The levels of low-density lipoprotein cholesterol (LDL-C), apolipoprotein (Apo) B and the
ratio of ApoAI/ApoB in Han but not in Mulao were different among the three genotypes (P< 0.05 for all), the
subjects with GG and CG genotypes had higher LDL-C, ApoB levels and lower ApoAI/ApoB ratio than the subjects
with CC genotype. Subgroup analysis showed that the G allele carriers in Han had higher total cholesterol (TC),
LDL-C and ApoB levels in males (P< 0.05) and lower ApoAI/ApoB ratio in both sexes (P< 0.05) than the G allele
noncarriers. The G allele carriers in Mulao had higher TC and LDL-C levels in males (P< 0.05) and lower high-density
lipoprotein cholesterol (HDL-C) levels in both sexes (P< 0.05) than the G allele noncarriers. Serum TC, LDL-C, ApoB
levels and ApoAI/ApoB ratio were correlated with genotypes in Han males (P< 0.05) but not in females. Serum lipid
parameters were also correlated with several environmental factors. The genotypes of rs2072183 SNP were
interacted with gender or cigarette smoking to influence serum TC and HDL-C levels in Mulao, whereas the
genotypes of rs2072183 SNP were interacted with several environmental factors to influence all seven lipid traits in
Han (P< 0.05-0.01).
Conclusions: The present study suggests that the rs2072183 SNP in NPC1L1 gene and its association with serum
lipid profiles are different between the Mulao and Han populations. The difference in serum lipid profiles between
the two ethnic groups might partly result from different rs2072183 SNP or NPC1L1 gene-environmental interactions.* Correspondence: yinruixing@yahoo.com.cn
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The increased incidence of cardiovascular disease (CVD)
in our today world has been linked to dyslipidemia. Un-
favorable lipid profiles include high levels of plasma or
serum total cholesterol (TC) [1,2], low-density lipoprotein
cholesterol (LDL-C) [3,4] and apolipoprotein (Apo) B
[5,6], and low levels of high-density lipoprotein cholesterol
(HDL-C) and ApoAI [7,8]. Especially, elevated TC and
LDL-C levels were well-established risk factors for athero-
sclerosis and coronary heart disease [2,9,10]. However, the
source of the serum lipids in human mainly relies on en-
dogenous synthesis and the intestinal absorption which
occupied more than 50% of the amount from dietary [11].
Interestingly, the fraction intestinal cholesterol absorption
ranges from 29-80% [12,13] and dietary influence on the
plasma cholesterol and LDL-C levels is extremely variable
among individuals [14]. Family history and twin studies
have shown that genetic polymorphism could account for
40-60% of the interindividual variation in plasma lipid
phenotypes [15-17]. Thus, these variations above to the
cholesterol homeostasis suggest that some polymorphisms
in the cholesterol absorption-related genes potentially
affect the blood lipid levels [18-20].
The Niemann-Pick type C1-like 1 (NPC1L1) protein
was identified as a cholesterol transporter and promoted
the absorption of cholesterol and plant sterol from the in-
testinal lumen [21-24]. Moreover, it was the molecular tar-
get of ezetimibe which was a cholesterol absorption
inhibitor verified to decrease TC and LDL-C levels
[21,25]. NPC1L1 is a glycosylated protein localized at the
brush-border membrane of the enterocyte [26]. The pro-
tein has the typical features of a membrane bound protein
with a signal peptide sequence, 13 predicted transmem-
brane domains, and extensive N-linked glycosylation sites
in the extracellular loop [27]. It also contains a sterol-
sensing domain encompassing ~180 amino acids [11] and
plays a critical role in cholesterol dependent regulation.
The expression of NPC1L1 in intestine parallels the effi-
ciency of cholesterol absorption along the gastrocolic axis,
with the highest level of NPC1L1 expression and choles-
terol absorption observed in the proximal jejunum and
minimal NPC1L1 expression and cholesterol absorption
in the ileum [27]. Furthermore, there is a small amount of
expressions in other tissues such as liver, stomach, gall-
bladder and testis [19]. Some animal studies have shown
that NPC1L1-deficient (NPC1L1−/−) mice were given
high cholesterol diet; however, these mice did not appear
hypercholesterolemia phenomenon caused by high choles-
terol diet, instead exhibited approximate 70% substantial
reduction in cholesterol absorption [20,21,23]. In vitro
study, cholesterol intake reduced by 30% in NPC1L1
knockout CaCo-2 epithelial cells compare to a control
group of normal CaCo-2 cells [28], and sterol uptake sig-
nificantly increased by NPC1L1 overexpressing CaCo-2epithelial cells in culture medium [23]. The human
NPC1L1 gene, located on chromosome 7p13, includes 20
exons and 19 introns. It has been demonstrated that sev-
eral variants in the NPC1L1 gene associated with choles-
terol absorption and the blood lipid levels accordingly
[14,20,29-31]. Several single nucleotide polymorphisms
(SNPs) at the NPC1L1 gene in human have been shown
to affect LDL-C lowing response to ezetimibe [32,33]. The
1735 C>G of rs2072183 SNP is in exon 2 and embedded
in the coding regions. At present, many studies have fo-
cused on the NPCILl SNPs and their haplotypes asso-
ciated with lipid levels sensitivity of the change which
caused by the treatment with ezetimibe. But the associ-
ation between rs2072183 SNP and blood lipid disorders
and coronary heart disease is limited.
China has a vast territory and 56 ethnic groups. Han is
the dominant ethnicity, and Mulao is a native minority
existing 207,352 people according to the fifth national cen-
sus statistics of China in 2000. A previous study has shown
that the genetic relationship between Mulao and other mi-
norities in Guangxi was much closer than that between
Mulao and Han or Uighur nationality [34]. The associations
of GALNT2, NCAN/CILP2/PBX4 and TRIB1 SNPs and
serum lipid levels have been reported in our previous stud-
ies in this population [35-37]. However, information on the
association of NPC1L1 SNPs and serum lipid profiles in the
Mulao and Han populations has not been reported previ-
ously. Thus, the aim of the present study was to detect the
association of NPC1L1 rs2072183 1735 C>G SNP and
several environmental factors with serum lipid parameters
in the Mulao and Han populations.Materials and methods
Study population
The study population included 688 subjects of Mulao and
738 participants of Han Chinese who reside in Luocheng
Mulao Autonomous County, Guangxi Zhuang Autono-
mous Region, People’s Republic of China. For the subjects
of Mulao, there were 288 (41.86%) males and 400 (58.14%)
females. The age ranged from 15 to 80 years, with an aver-
age age of 52.13±14.16 years. For the participants of Han,
there were 274 men (37.13%) and 464 women (62.87%).
The age ranged from 15 to 80 years, with an average age of
52.13±14.16 years. All of the subjects were randomly
selected from our stratified randomized cluster samples. All
of them were rural agricultural workers. No significant evi-
dence indicated that they suffer from any chronic illness, in-
cluding hepatic, renal, or thyroid. We excluded the subjects
who had a history of heart attack or myocardial infarction,
stroke, congestive heart failure, diabetes or fasting blood
glucose≥7.0 mmol/L determined by glucose meter. Sub-
jects were not allowed to take agents of fibrates, statins, and
hormones which impact on lipid metabolism or absorption.
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study was approved by the Ethics Committee of the First
Affiliated Hospital, Guangxi Medical University.Epidemiological survey
The survey was carried out using internationally standar-
dized criteria, following a common protocol [38]. Informa-
tion on demographics, socioeconomic status, and lifestyle
factors was collected with standardized questionnaires. The
alcohol information included questions about the number of
liangs (about 50 g) of rice wine, corn wine, rum, beer, or li-
quor consumed during the preceding 12 months. Alcohol
consumption was divided into three gradations: nondrinker
(0), < 25 and≥25 grams per day. Smoking status was also
divided into three gradations: nonsmoker (0), < 20 and≥20
cigarettes per day. At the physical examination, several para-
meters, such as height, weight, and waist circumference were
measured. Body weight, to the nearest 50 grams, was mea-
sured using a portable balance scale. Subjects were weighed
without shoes and in a minimum of clothing. Height was
measured, to the nearest 0.5 cm, using a portable steel meas-
uring device. Body mass index (BMI) was calculated as weigh
in kg divided by the square of height in meters (kg/m2). Sit-
ting blood pressure was measured three times with the use
of a mercury sphygmomanometer after the subjects had a 5-
minute rest, and the average of the three measurements was
used for the level of blood pressure. Systolic blood pressure
was determined by the first Korotkoff sound, and diastolic
blood pressure by the fifth Korotkoff sound.Biochemical analysis
A venous blood sample of 5 mL was obtained from all
subjects after an overnight fast. A part of the sample
(2 mL) was collected into glass tubes and allowed to clot
at room temperature, and used to measure serum lipid
levels. Another part of the sample (3 mL) was transferred
to tubes with anticoagulate solution (4.80 g/L citric acid,
14.70 g/L glucose, and 13.20 g/L tri-sodium citrate) and
used to extract DNA. Immediately following clotting
serum was separated by centrifugation for 15 minutes at
3000 rpm. The levels of TC, triglyceride (TG), HDL-C,
and LDL-C in samples were determined by enzymatic
methods with commercially available kits, Tcho-1, TG-LH
(RANDOX Laboratories Ltd., Ardmore, Diamond Road,
Crumlin Co. Antrim, United Kingdom, BT29 4QY), Cho-
lestest N HDL, and Cholestest LDL (Daiichi Pure Chemi-
cals Co., Ltd., Tokyo, Japan); respectively. Serum ApoAI
and ApoB levels were detected by the immunoturbidi-
metric immunoassay using a commercial kit (RANDOX
Laboratories Ltd.). All determinations were performed
with an autoanalyzer (Type 7170A; Hitachi Ltd., Tokyo,
Japan) in the Clinical Science Experiment Center of the
First Affiliated Hospital, Guangxi Medical University.DNA amplification and genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using the phenol-chloroform method [39-42]. The
extracted DNA was stored at 4 °C for the next experiment.
The analyses of rs2072183 1735 C>G (trivial name
L272L) SNP were performed by polymerase chain reaction
and restriction fragment length polymorphism (PCR-
RFLP). We amplified a 437 bp fragment using primers 5'-
GGGATGACAGATAGCACCAA-3' (forward) and 5'-
GACATCACCTTCCACCTCTTG-3' (reverse) (Sangon,
Shanghai, People’s Republic of China). Each amplification
reaction was performed using 100 ng genomic DNA in 25
μL of reaction mixture consisting of 1.0 μL of each primer
(10 μmol/L), 12.5 μL 2×Taq PCR MasterMix (constitu-
ent: 0.1 U Taq polymerase/μL, 500 μM dNTP each and
PCR buffer;Tiangen, Beijing, People’s Republic of China)
and 8.5 μL of ddH2O (DNase/RNase-free). The reaction of
PCR begin as denaturizing at 95 °C for 5 min, then fol-
lowed by 30 cycles of 30 s denaturation at 94 °C, 30 s
annealing at 60 °C and extension 30 s at 72 °C, and the
third stage was a final 8 min extension at 72 °C. After elec-
trophoresis on a 2.0% agarose gel with 0.5 μg/mL ethidium
bromide, the PCR products were visualized under ultravio-
let light. Then 6 μL PCR amplifications were digested with
5 U Taq I restriction enzyme (Ferment) at 65 °C for 12
hours. After restriction enzyme digestion of the amplified
DNA, genotypes were identified by electrophoresis on 2.0%
agarose gels and visualized with ethidium-bromide staining
ultraviolet illumination. The genotypes were scored by an
experienced reader blinded to epidemiological data and
serum lipid levels. Six samples (CC, CG and GG genotypes
in two; respectively) detected by the PCR-RFLP were also
confirmed by direct sequencing. The PCR products were
purified by low melting point gel electrophoresis and phe-
nol extraction, and then the DNA sequences were analyzed
in Shanghai Sangon Biological Engineering Technology &
Services Co., Ltd., People’s Republic of China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI, ApoB levels, and the ratio of ApoAI to ApoB in
our Clinical Science Experiment Center were 3.10-5.17,
0.56-1.70, 0.91-1.81, 2.70-3.20 mmol/L, 1.00-1.78, 0.63-
1.14 g/L, and 1.00-2.50; respectively. The individuals with
TC> 5.17 mmol/L and/or TG> 1.70 mmol/L were
defined as hyperlipidemic [43,44]. Hypertension was diag-
nosed according to the criteria of 1999 World Health
Organization-International Society of Hypertension Guide-
lines for the management of hypertension [45,46]. The
diagnostic criteria of overweight and obesity were accord-
ing to the Cooperative Meta-analysis Group of China
Obesity Task Force. Normal weight, overweight and obes-
ity were defined as a BMI< 24, 24–28, and> 28 kg/m2;
respectively [47].
Table 1 Comparison of demography, lifestyle and serum
lipid levels between the Mulao and Han populations
Parameter Han Mulao t (2) P
Number 738 688 – –
Male/female 274/464 288/400 3.340 0.068
Age (years) 51.95 ± 15.43 52.13 ± 14.16 −0.216 0.829
Height (cm) 154.11 ± 7.45 155.11 ± 8.21 −2.397 0.017
Weight (kg) 53.11 ± 8.72 53.03 ±9.51 0.177 0.859
Body mass index (kg/m2) 22.31 ± 2.98 21.97 ± 3.07 2.120 0.034
wrist circumference(cm) 75.17 ±7.77 75.29 ± 8.64 −0.276 0.783
Systolic blood pressure
(mmHg)
129.95 ± 19.12 129.86 ± 21.90 −0.084 0.933
Diastolic blood pressure
(mmHg)
82.40 ±10.96 81.15 ± 11.69 2.075 0.038
Pulse pressure (mmHg) 47.54 ± 14.55 48.70 ± 16.58 −1.398 0.164
Glucose 6.02 ± 1.65 6.00 ± 1.58 0.224 0.823
Cigarette smoking [n (%)]
Nonsmoker 561(76.02) 518 (75.29)
≤20 cigarettes/day 160(21.68) 141(20.49)
>20 cigarettes/day 17 (2.30) 29 (4.22) 4.296 0.117
Alcohol consumption [n (%)]
Nondrinker 601 (81.44) 519 (75.44)
≤25 g/day 67 (9.08) 56 (8.14)
>25 g/day 70 (9.48) 113(16.42) 15.357 0.000
Total cholesterol (mmol/L) 4.99 ± 1.10 5.07 ± 1.13 −1.297 0.195
Triglyceride (mmol/L) 1.07 (0.89) 1.08 (0.79) −0.367 0.714
HDL-C (mmol/L) 1.73 ± 0.53 1.75 ± 0.43 −1.107 0.268
LDL-C (mmol/L) 2.88 ± 0.88 2.97 ± 0.88 −1.988 0.047
Apolipoprotein (Apo)
AI (g/L)
1.33 ± 0.26 1.34 ± 0.39 −0.230 0.821
Apo B (g/L) 0.85 ± 0.21 0.99 ± 0.56 −6.312 0.000
Apo AI/Apo B 1.64 ± 0.49 1.58 ± 0.75 1.852 0.068
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol. The value of triglyceride was presented as median (interquartile
range), the difference between the two ethnic groups was determined by the
Wilcoxon-Mann–Whitney test.
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Epidemiological data were recorded on a pre-designed
form and managed with Excel software. Quantitative vari-
ables are expressed as mean± standard deviation (serum
TG levels are presented as medians and interquartile
ranges). Qualitative variables are expressed as percentages.
Allele frequency was estimated by gene counting, and the
standard goodness-of-fit test was used to test the Hardy-
Weinberg equilibrium. Chi-square test was used to com-
pare the difference in genotype distribution between the
populations. The difference in general characteristics be-
tween Mulao and Han was tested by the Student’s un-
paired t-test. The association of genotypes and serum lipid
parameters was tested by covariance analysis (with sex,
age, BMI, blood pressure, wrist circumference, blood glu-
cose, alcohol consumption, cigarette smoking as covari-
ates). In order to evaluate the association of serum lipid
levels with genotypes (CC=1, CG=2, GG=3) and several
environmental factors, multiple linear regression analysis
with forward stepwise modeling was also performed in the
combined population of Mulao and Han, Mulao, Han; re-
spectively. Potential interactions between NPC1L1 1735 C
>G polymorphism and several environmental factors on
serum lipid phenotypes were tested using the factorial de-
sign covariance analysis after controlling for potential con-
founders in Mulao and Han; respectively. All reported P
values were from two-sided tests and less than 0.05 was
considered to be statistically significant. All statistical ana-
lyses performed using software package SPSS 13.0 (SPSS
Inc., Chicago, Illinois).
Results
General characteristics and serum lipid levels
Table 1 gives the general characteristics and serum lipid
levels between Mulao and Han populations. The levels
of height, serum LDL-C, ApoB and the percentages of
subjects who consumed heavy alcohol were higher in
Mulao than in Han Chinese (P< 0.05-0.001), whereas
the levels of BMI and diastolic blood pressure were
lower in Mulao than in Han (P< 0.05). There were no
significant differences in the levels of weight, wrist cir-
cumference, systolic blood pressure, pulse pressure,
blood glucose, serum TC, TG, HDL-C, ApoAI, the ratio
of ApoAI to ApoB, age structure, the percentages of sub-
jects who smoked cigarettes, or the ratio of male to fe-
male between the two ethnic groups (P> 0.05 for all).
Results of electrophoresis and genotyping
After the genomic DNA of the samples was amplified by
PCR and imaged by 2.0% agarose gel electrophoresis, the
purpose gene of 437 bp nucleotide sequences could be
found in all samples (Figure 1). The genotypes identified
were named according to the presence or absence of the
enzyme restriction sites, when a G to C transversion at1735 locus of the NPC1L1 gene. The absence of the cut-
ting site indicates the C allele; while its presence indi-
cates the G allele (can be cut). Thus, the CC genotype is
homozygote for the absence of the site (band at 437 bp),
CG genotype is heterozygote for the absence and pres-
ence of the site (bands at 437-, 268- and 169-bp), and
GG genotype is homozygote for the presence of the site
(bands at 268- and 169-bp; Figure 2).Genotypic and allelic frequencies
The genotypic and allelic frequencies of rs2072183 SNP
are shown in Table 2. The frequency of C and G alleles
was 70.28% and 29.72% in Mulao, and 62.74% and
Figure 1 Electrophoresis of PCR products of the samples. Lane
M, 100 bp marker ladder; lanes 1–5, samples. The 437 bp bands are
the target genes.
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of CC, CG and GG genotypes was 49.85%, 40.84% and
9.31% in Mulao, and 39.30%, 46.88% and 13.82% in Han
(P< 0.001); respectively. There was no significant differ-
ence in the genotypic and allelic frequencies between
males and females in both ethnic groups. The genotype
distribution abides to the Hardy-Weinberg principle.Figure 2 Genotyping of the rs2072183 SNP. Lane M, 100 bp
marker ladder; lanes 1 and 2, CC genotype (437 bp); lanes 3 and 4,
CG genotype (437-, 268- and 169-bp); and lane 5, GG genotype
(268- and 169-bp).Results of sequencing
The results were shown as CC, CG and GG genotypes
by PCR-RFLP, the CC, CG and GG genotypes were also
confirmed by sequencing (Figure 3); respectively.
Genotypes and serum lipid levels
As shown in Table 3, the levels of LDL-C, ApoB and the
ratio of ApoAI to ApoB in Han but not in Mulao were
different among the three genotypes (P< 0.05 for all),
the subjects with GG and CG genotypes had higher
LDL-C, ApoB levels and lower the ratio of ApoAI to
ApoB than the subjects with CC genotype. When serum
lipid levels were analyzed according to sex, the G allele
carriers in Han had higher serum TC, LDL-C and ApoB
levels in males (P< 0.05) and lower the ratio of ApoAI
to ApoB in both sexes (P< 0.05) than the G allele non-
carriers. The G allele carriers in Mulao had higher
serum TC and LDL-C levels in males (P< 0.05) and
lower HDL-C levels in both sexes (P< 0.05) than the G
allele noncarriers. There was no significant difference in
the remaining serum lipid parameters among the three
genotypes in Mulao, Han, males, or females (P> 0.05 for
all); respectively.
Relative factors for serum lipid parameters
Multiple linear regression analysis showed that serum
LDL-C levels were correlated with genotypes in the com-
bined population of Mulao and Han (P< 0.05). Serum
LDL-C and ApoB levels were correlated with genotypes in
Han (P< 0.05 for each) but not in Mulao (Table 4). When
the association of rs2072183 genotypes and serum lipidTable 2 Comparison of the genotype and allele
frequencies of rs2072183 SNP in Mulao and Han Chinese
[n (%)]
Group n Genotype allelic Allele
CC CG GG C G
Han 738 290(39.30) 346(46.88) 102(13.82) 926(62.74) 550(37.26)
Mulao 688 343(49.85) 281 (40.84) 64 (9.31) 967(70.28) 409(29.72)
2 – 18.144 18.135
P – 0.000 0.000
Han
Male 274 100(36.50) 138(50.36) 36(13.14) 338(61.68) 210(38.32)
Female 464 190(40.95) 208 (44.83) 66(14.22) 588(63.36) 340(36.64)
χ2 – 2.142 0.418
P – 0.343 0.518
Mulao
Male 288 146 (50.70) 118(40.97) 24(8.33) 410(70.93) 168(29.07)
Female 400 197(49.25) 163(40.75) 40(10.00) 557(69.63) 243(30.37)
χ2 – 0.572 0.275
P – 0.751 0.600
Figure 3 A part of the nucleotide sequence of rs2072183 SNP. (A) CC genotype; (B) CG genotype; (C) GG genotype.
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levels of LDL-C, ApoB and the ratio of ApoAI to ApoB in
Han were correlated with genotypes in males (P< 0.05 for
all, Table 5) but not in females. Serum lipid parameters
were also correlated with gender, age, BMI, wrist circum-
ference, alcohol consumption, cigarette smoking, blood
pressure and blood glucose in both ethnic groups
(Table 4).
Interaction between rs2072183 SNP and several
environmental factors on serum lipid phenotypes
Interaction between rs2072183 genotypes and gender or
cigarette smoking was shown to influence serum TC and
HDL-C levels in Mulao, whereas interaction between
rs2072183 SNP and several environmental factors were
found to influence all seven lipid traits in Han (P< 0.05-
0.01; Table 6).
Discussion
Our investigation revealed that the levels of serum LDL-C
and ApoB were higher in Mulao than in Han Chinese.
There was no significant difference in the levels of TC,
TG, HDL-C, ApoAI and the ratio of ApoAI to ApoB be-
tween the two ethnic groups. It was widely realized that
dyslipidemia as a serious risk factor for CVD caused by
various elements, mainly including genetic and environ-
mental factors and their interaction [41-44]. Concerning
the customs of Mulao minority, the young were betrothed
with the deliberation by both families when they were in
childhood, usually with the girl being four or five years
older than the boy. Usually the maternal female cousinwas the priority target for marriage. The girl got married
at an early age and remained with her natal family until
her first child was born. Till then she was free to join the
young men and women who came together for responsive
singing, flirtations, and courtships at festival times. Divorce
and remarriage were permitted, with little restriction. The
two-generation household is the most common unit of
residence. Households are under the control of the father,
and divide when the sons marry, with only the youngest
son remaining with the parents. Owing to its own unique
marriage system, so we speculate that the genetic poly-
morphisms of the lipid-associated genes in Mulao may be
different from those in the local Han residents.
The present study showed that the allelic and geno-
typic distribution of rs2072183 SNP was different in the
Mulao and Han populations. The frequency of G allele
was 29.72% in Mulao and 37.26% in Han (P< 0.001); re-
spectively. The frequency of GG genotype in Han was
also higher than that in Mulao (13.82% vs. 9.31%). There
was no significant difference in the allelic and genotypic
frequencies between males and females in the both eth-
nic groups. The frequency of minor allele (NPC1L1
1735 G) in our study was also different from that in sev-
eral previous studies. Hegele et al. [33] reported that the
frequency of G allele was 25.0% and the frequencies of
CC and GG genotypes were 55% and 5% in 101 Canad-
ian patients with primary hypercholesterolemia. They
also found that there was moderate but not strong link-
age disequilibrium (LD) among 1735 C>G, 27677 T>C
and 25342A>C, the most common haplotype was
defined as 1735 C-25342A-27677 T whose frequency
Table 3 Genotypes of the rs2072183 SNP and serum lipid levels between the Mulao and Han populations
Genotype n TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L) ApoAI (g/L) ApoB (g/L) ApoAI/ApoB
Han
CC 290 4.90 ± 0.97 1.07(0.88) 1.70 ± 0.41 2.74 ± 0.77 1.34 ± 0.26 0.82 ± 0.20 1.72 ± 0.52
CG 346 5.05 ± 1.20 1.12(0.87) 1.74 ± 0.64 2.96 ± 0.92 1.33 ± 0.27 0.86 ± 0.21 1.59 ± 0.46
GG 102 5.14 ± 1.09 0.95(0.99) 1.75 ± 0.44 3.04 ± 0.97 1.32 ± 0.23 0.89 ± 0.22 1.59 ± 0.53
F – 1.874 1.491 1.059 5.418 0.200 3.430 4.303
P – 0.154 0.474 0.347 0.005 0.819 0.033 0.014
CC 290 4.90 ± 0.97 1.07(0.88) 1.70 ± 0.41 2.74 ± 0.77 1.34 ± 0.26 0.82 ± 0.20 1.72 ± 0.52
CG/GG 448 5.07 ± 1.18 1.06(0.89) 1.74 ± 0.60 2.98 ± 0.93 1.32 ± 0.26 0.87 ± 0.21 1.60 ± 0.47
F – 3.650 −0.972 2.080 10.845 0.397 6.741 8.067
P – 0.056 0.331 0.150 0.001 0.529 0.010 0.005
Male
CC 100 5.06 ± 0.92 1.23(1.28) 1.61 ± 0.45 2.75 ± 0.77 1.36 ± 0.30 0.89 ± 0.20 1.59 ± 0.49
CG 138 5.35 ± 1.20 1.18(0.86) 1.73 ± 0.42 3.03 ± 0.86 1.38 ± 0.29 0.92 ± 0.21 1.57 ± 0.44
GG 36 5.39 ± 1.26 1.29(2.12) 1.56 ± 0.34 3.26 ± 0.92 1.24 ± 0.16 1.01 ± 0.23 1.28 ± 0.25
F – 3.231 0.946 2.388 4.764 2.197 4.664 5.021
P – 0.041 0.623 0.094 0.009 0.113 0.010 0.007
CC 100 5.01 ± 0.92 1.23(1.28) 1.61 ± 0.45 2.75 ± 0.77 1.36 ± 0.30 0.89 ± 0.20 1.59 ± 0.49
CG/GG 174 5.36 ± 1.20 1.22(0.92) 1.69 ± 0.41 3.08 ± 0.88 1.35 ± 0.27 0.94 ± 0.21 1.51 ± 0.42
F – 6.460 −0.789 2.775 8.980 0.003 4.269 2.550
P – 0.012 0.430 0.097 0.003 0.954 0.040 0.111
Female
CC 190 4.81 ± 0.98 1.04(0.78) 1.75 ± 0.38 2.73 ± 0.77 1.33 ± 0.24 0.79 ± 0.19 1.79 ± 0.52
CG 208 4.84 ± 1.68 0.97(0.80) 1.75 ± 0.75 2.91 ± 0.96 1.29 ± 0.26 0.83 ± 0.20 1.62 ± 0.45
GG 66 5.01 ± 1.02 0.85(0.82) 1.85 ± 0.45 2.92 ± 0.97 1.37 ± 0.25 0.82 ± 0.18 1.77 ± 0.56
F – 0.383 2.241 0.913 1.799 2.368 1.676 5.916
P – 0.682 0.326 0.402 0.167 0.095 0.188 0.003
CC 190 4.81 ± 0.98 1.04(0.78) 1.75 ± 0.38 2.73 ± 0.77 1.33 ± 0.24 0.79 ± 0.19 1.79 ± 0.52
CG/GG 274 4.89 ± 1.13 0.96(0.80) 1.78 ± 0.68 2.91 ± 0.96 1.30 ± 0.26 0.83 ± 0.20 1.65 ± 0.49
F – 0.201 −1.025 0.380 3.527 1.285 2.910 6.656
P – 0.654 0.305 0.538 0.061 0.257 0.089 0.010
Mulao
CC 343 5.08 ± 1.11 1.07(0.72) 1.76 ± 0.43 2.96 ± 0.87 1.35 ± 0.39 0.99 ± 0.56 1.60 ± 0.71
CG 280 5.10 ± 1.16 1.10(0.88) 1.75 ± 0.44 3.01 ± 0.93 1.32 ± 0.41 1.01 ± 0.60 1.56 ± 0.83
GG 64 4.90 ± 1.10 1.14(0.82) 1.75 ± 0.46 2.88 ± 0.77 1.33 ± 0.39 0.86 ± 0.27 1.63 ± 0.56
F – 0.521 0.603 0.004 0.324 0.229 1.503 0.040
P – 0.594 0.740 0.996 0.723 0.742 0.223 0.961
CC 343 5.08 ± 1.11 1.07(0.72) 1.76 ± 0.43 2.96 ± 0.87 1.35 ± 0.39 0.99 ± 0.56 1.60 ± 0.71
CG/GG 344 5.06 ± 1.15 1.10(0.86) 1.75 ± 0.44 2.99 ± 0.90 1.32 ± 0.40 0.98 ± 0.55 1.58 ± 0.79
F – 0.112 −0.764 0.008 0.008 0.586 0.081 0.010
P – 0.738 0.445 0.931 0.928 0.444 0.776 0.919
Male
CC 146 5.05 ± 1.04 1.17(0.96) 1.71 ± 0.45 2.85 ± 0.75 1.39 ± 0.38 1.09 ± 0.68 1.54 ± 0.66
CG 118 5.34 ± 0.97 1.09(1.05) 1.83 ± 0.43 3.08 ± 0.85 1.36 ± 0.46 1.06 ± 0.61 1.49 ± 0.67
GG 24 4.89 ± 1.20 1.39(1.26) 1.73 ± 0.51 2.80 ± 0.71 1.36 ± 0.40 0.90 ± 0.32 1.62 ± 0.60
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Table 3 Genotypes of the rs2072183 SNP and serum lipid levels between the Mulao and Han populations (Continued)
F – 4.185 0.775 2.964 3.065 0.073 0.836 0.614
P – 0.016 0.679 0.053 0.038 0.930 0.435 0.542
CC 146 5.05 ± 1.04 1.17(0.96) 1.71 ± 0.45 2.85 ± 0.75 1.39 ± 0.38 1.09 ± 0.68 1.54 ± 0.66
CG/GG 142 5.27 ± 1.02 1.12(1.02) 1.82 ± 0.45 3.03 ± 0.84 1.36 ± 0.45 1.03 ± 0.57 1.51 ± 0.66
F – 3.075 −0.259 4.875 3.186 0.140 0.414 0.185
P – 0.081 0.796 0.028 0.075 0.709 0.521 0.668
Female
CC 197 5.09 ± 1.16 1.02(0.59) 1.80 ± 0.40 3.04 ± 0.94 1.32 ± 0.39 0.92 ± 0.43 1.63 ± 0.75
CG 162 4.92 ± 1.25 1.10(0.66) 1.68 ± 0.43 2.96 ± 0.98 1.29 ± 0.37 0.98 ± 0.59 1.62 ± 0.93
GG 40 4.91 ± 1.04 0.99(0.74) 1.76 ± 0.42 2.93 ± 0.80 1.30 ± 0.38 0.84 ± 0.24 1.64 ± 0.55
F – 1.215 2.093 2.518 0.546 0.199 1.106 0.056
P – 2.989 0.351 0.082 0.580 0.820 0.332 0.946
CC 197 5.09 ± 1.16 1.02(0.59) 1.80 ± 0.40 3.04 ± 0.94 1.32 ± 0.39 0.92 ± 0.43 1.63 ± 0.75
CG/GG 202 4.92 ± 1.22 1.09(0.68) 1.70 ± 0.43 2.95 ± 0.95 1.29 ± 0.37 0.95 ± 0.84 1.62 ± 0.87
F – 2.247 −1.364 4.146 0.963 0.364 0.661 0.020
P – 0.135 0.172 0.042 0.327 3.547 0.417 0.888
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B; ApoAI/ApoB, the ratio of apolipoprotein AI to apolipoprotein B. The value of TG was presented as median (interquartile range). The difference
among the genotypes was determined by the Kruskal-Wallis test or the Wilcoxon-Mann–Whitney test.
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http://www.lipidworld.com/content/11/1/61was 61.9%. Furthermore, Siomon et al. [32] reported
that the minor allele (G) frequency was 21.9%, 28.3%
and 17.9% in healthy Caucasians, African American and
Hispanics; respectively. Among Asian populations, Chen
et al. [20] screened the promoter and coding regions of
NPC1L1 gene for genetic polymorphisms from 50 Chin-
ese Taiwanese, and revealed that the two common SNPs
of 1735 C>G and -762 T>C were highly linked (D'va-
lue = 0.7459, P< 0.0001). The frequency of G allele was
35.7% and the frequencies of CC and GG genotypes
were 39.29% and 10.71%; respectively. These results were
similar to those of our Han population. The frequencies
of G allele and GG genotype promulgated by Maeda et
al. [30] were 41.90% and 19.01% in Japanese, and were
higher than those in Han Chinese. These results indicate
that the prevalence of 1735 G allele variants in the
NPC1L1 gene may have an ethnic specificity.
Several previous studies reported that the rs2072183
SNP could cause significant change in serum TC, LDL-C
and ApoB levels independently, but others did not find
the correlations. An authoritative primary meta-analysis
containing 46 participating studies in the world revealed
that the mutation of rs2072183 had an important correl-
ation with serum TC and LDL-C levels [48]. Polisecki et
al. [29] have demonstrated that this SNP was associated
with slightly higher TC, LDL-C, and ApoB in elder Euro-
pean males and females, with 1735GG carriers had higher
LDL-C levels compared with CC and CG carriers. How-
ever, Siomon et al. [32] reported that this SNP was not
related to basal cholesterol concentration in 375 appar-
ently healthy individuals which consist of 198 Caucasians,99 African Americans and 78 Hispanics. Zhao et al. [24]
also showed a similar result in 82 hypercholesterolemic
men. Nevertheless, Zhao et al. found that rs2072183 SNP
could increase the responsiveness to plant sterols. Hetero-
zygous carriers demonstrated a trend of an enhanced chol-
esterol lowering effect in response to plant sterols
intervention, as compared to homozygous counterparts
[24]. On the contrary, the mutant G allele carriers (n=37)
showed a trend of a greater reduction in serum TC
(−9.8 ± 2.0% vs. -4.1 ± 1.6%, P=0.057) and LDL-C
(−14.5± 3.3% vs. -4.4 ± 2.5%, P=0.082) in comparison with
their wild type counterparts (C/C, n=42). Thus the poly-
morphisms could be useful in devising individualized chol-
esterol lowering strategies [24]. Likewise, Maeda et al. [30]
found that the presence of G allele had no effect on serum
TC, HDL-C, LDL-C and ApoB levels, there was no signifi-
cant difference among the CC, CG and GG genotypes in
139 Japanese. But when makers of cholesterol synthesis/
absorption were compared between the GG and CG/CC
genotypes, the campesterol level was significantly higher
in the GG than CG/CC genotypes, and the sitosterol level
tended to be higher. Chen et al. [20] also reported the
genetypic distribution of rs2072183 SNP did not differ sig-
nificantly between serum cholesterol level< 24 and> 24
groups (P> 0.05) in Chinese Taiwanese. In addition, some
haplotypes were related with the polymorphism site have
been given especial concern. For instance, the variation
company with two haplotype blocks (TaqSNP:-18A>C
and U328650A>G) formed haplotypes. A test showed
that carriers of common haplotype (−18A-1735 C-
U328650A>G) had 1.8 mg/dl lower baseline LDL-C than
Table 4 Correlative factors for serum lipid parameters between the Mulao and Han populations
Lipid parameter Risk factor Unstandardized coefficient Std. error Standardized coefficient t P
Mulao plus Han
TC Wrist circumference 0.022 0.004 0.159 6.001 0.000
Age 0.012 0.002 0.154 5.864 0.000
Alcohol consumption 0.169 0.042 0.105 4.066 0.000
Diastolic blood pressure 0.008 0.003 0.083 3.067 0.002
TG Wrist circumference 0.055 0.006 0.245 9.379 0.000
Alcohol consumption 0.240 0.078 0.090 3.089 0.002
Blood glucose 0.098 0.030 0.086 3.309 0.001
Cigarette smoking 0.302 0.103 0.084 2.930 0.003
Diastolic blood pressure 0.011 0.004 0.069 2.600 0.009
Age −0.007 0.003 −0.056 −2.092 0.037
HDL-C Wrist circumference −0.008 0.002 −0.127 −3.261 0.001
Alcohol consumption 0.120 0.022 0.170 5.419 0.000
Age 0.002 0.001 0.07 2.732 0.006
Gender 0.099 0.032 0.099 3.09 0.002
Body mass index −0.019 0.006 −0.116 −3.054 0.002
LDL-C Age 0.011 0.002 0.187 7.331 0.000
Wrist circumference 0.012 0.004 0.107 2.846 0.004
Body mass index 0.029 0.011 0.099 2.638 0.008
Ethnic group 0.12 0.046 0.068 2.635 0.009
Alcohol consumption −0.076 0.033 −0.06 −2.301 0.022
Genotype −0.073 0.034 −0.056 −2.179 0.030
ApoAI Alcohol consumption 0.108 0.013 0.224 8.558 0.000
Wrist circumference −0.004 0.001 −0.089 −3.400 0.001
Age 0.001 0.001 0.055 2.133 0.033
ApoB Wrist circumference 0.010 0.001 0.185 7.025 0.000
Ethnic group 0.133 0.021 0.159 6.287 0.000
Blood glucose 0.024 0.007 0.093 3.638 0.000
Gender −0.068 0.022 −0.079 −3.042 0.002
Systolic blood pressure 0.001 0.001 0.071 2.728 0.006
ApoAI/ApoB Wrist circumference −0.012 0.003 −0.150 −3.882 0.000
Blood glucose −0.030 0.010 −0.077 −2.919 0.004
Age −0.003 0.001 −0.070 −2.679 0.007
Alcohol consumption 0.127 0.028 0.139 4.474 0.000
Gender 0.177 0.041 0.137 4.333 0.000
Body mass index −0.023 0.008 −0.108 −2.867 0.004
Ethnic group −0.075 0.032 −0.059 −2.318 0.021
Mulao
TC Wrist circumference 0.022 0.005 0.170 4.538 0.000
Age 0.011 0.003 0.132 3.525 0.000
TG Wrist circumference 0.046 0.006 0.227 7.620 0.000
Alcohol consumption 0.305 0.069 0.161 4.431 0.000
HDL-C Body mass index −0.022 0.007 −0.161 −3.045 0.002
Alcohol consumption 0.094 0.021 0.163 4.462 0.000
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Table 4 Correlative factors for serum lipid parameters between the Mulao and Han populations (Continued)
Wrist circumference −0.008 0.003 −0.153 −2.890 0.004
Age 0.003 0.001 0.095 2.609 0.009
LDL-C Body mass index 0.052 0.011 0.183 4.911 0.000
Age 0.009 0.002 0.144 3.865 0.000
Alcohol consumption −0.095 0.044 −0.081 −2.186 0.029
ApoAI Alcohol consumption 0.107 0.020 0.202 5.344 0.000
Wrist circumference −0.003 0.002 −0.075 −1.982 0.048
ApoB Wrist circumference 0.012 0.002 0.191 5.098 0.000
Blood glucose 0.030 0.013 0.085 2.257 0.024
ApoAI/ApoB Wrist circumference −0.019 0.003 −0.218 −5.803 0.000
Alcohol consumption 0.143 0.043 0.143 3.329 0.001
Cigarette smoking −0.163 0.060 −0.116 −2.726 0.007
Blood glucose −0.041 0.018 −0.086 −2.294 0.022
Han Chinese
TC Diastolic blood pressure 0.016 0.004 0.160 4.300 0.000
wrist circumference 0.022 0.005 0.157 4.312 0.000
Age 0.009 0.003 0.131 3.518 0.000
Gender −0.231 0.081 −0.101 −2.841 0.005
Blood glucose 0.048 0.024 0.072 2.013 0.044
TG Wrist circumference 0.092 0.015 0.330 6.132 0.000
Gender −0.422 0.161 −0.094 −2.627 0.009
Blood glucose 0.146 0.047 0.111 3.083 0.002
Diastolic blood pressure 0.025 0.007 0.125 3.357 0.001
Age −0.013 0.005 −0.092 −2.462 0.014
Body mass index −0.089 0.038 −0.123 −2.34 0.020
HDL-C Wrist circumference −0.012 0.003 −0.175 −4.834 0.000
LDL-C Age 0.013 0.002 0.219 6.262 0.000
Wrist circumference 0.021 0.004 0.188 5.364 0.000
Genotype −0.220 0.063 −0.122 −3.495 0.001
ApoAI Body mass index −0.012 0.003 −0.134 −3.660 0.000
Gender −0.045 0.020 −0.083 −2.266 0.024
ApoB Wrist circumference 0.008 0.001 0.285 8.291 0.000
Systolic blood pressure 0.001 0.000 0.080 1.798 0.073
Blood glucose 0.021 0.004 0.165 5.008 0.000
Gender −0.062 0.015 −0.146 −4.246 0.000
Genotype −0.037 0.014 −0.086 −2.656 0.008
Diastolic blood pressure 0.002 0.001 0.101 2.318 0.021
ApoAI/ApoB Body mass index −0.032 0.007 −0.197 −4.794 0.000
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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http://www.lipidworld.com/content/11/1/61other haplotypes [29]. These data manifested that the vari-
ation and haplotype were significantly associated with
LDL-C levels, and the homozygotes carriers for the minor
allele had the higher LDL-C level. The most frequent
combination 1735 C-25342A-27677 T was defined as
haplotype 2 and all the other haplotypes as haplotype X.Interestingly, all of Maeda et al. [30] and Hegele et al. [33]
showed that the levels of serum TC, TG, HDL-C and
LDL-C have no significant difference among these haplo-
types. In the present study, we showed that the levels of
LDL-C, ApoB and the ratio of ApoAI to ApoB in Han but
not in Mulao were different among the three genotypes,
Table 5 Correlative factors for serum lipid parameters
between males and females in both ethnic groups
Lipid
parameter






0.029 0.006 0.284 5.015 0.000
Alcohol consumption 0.227 0.076 0.168 2.984 0.003
Blood glucose 0.093 0.036 0.151 2.709 0.007
Genotype −0.302 0.129 −0.130 −2.346 0.020
Wrist circumference 0.016 0.008 0.116 2.024 0.044
TG Wrist circumference 0.115 0.022 0.298 5.174 0.000
Cigarette smoking 0.934 0.304 0.177 3.073 0.002
HDL-C Body mass index −0.052 0.008 −0.371 −6.279 0.000
Alcohol consumption 0.108 0.029 0.210 3.695 0.000
Diastolic blood
pressure
0.006 0.002 0.164 2.809 0.005
LDL-C Genotype −0.218 0.076 −0.169 −2.87 0.005
Cigarette smoking −0.224 0.086 −0.155 −2.596 0.010
Body mass index 0.038 0.017 0.134 2.276 0.024
ApoAI Alcohol consumption 0.126 0.019 0.369 6.546 0.000
Body mass index −0.025 0.005 −0.270 −4.686 0.000
Diastolic blood
pressure
0.003 0.001 0.128 2.277 0.024
Cigarette smoking 0.059 0.027 0.124 2.208 0.028
ApoB Wrist circumference 0.008 0.001 0.294 5.399 0.000
Diastolic blood
pressure
0.004 0.001 0.228 4.230 0.000
Blood glucose 0.022 0.006 0.184 3.450 0.001
Alcohol consumption 0.037 0.013 0.148 2.753 0.006
Genotype −0.043 0.017 −0.137 −2.586 0.010
ApoAI/Apo B Body mass index −0.061 0.008 −0.412 −7.541 0.000
Alcohol consumption 0.108 0.030 0.200 3.647 0.000
Genotype 0.097 0.036 0.144 2.681 0.008
Blood glucose −0.030 0.014 −0.118 −2.185 0.030
Han/female
TC Alcohol consumption −0.477 0.230 −0.091 −2.073 0.039
Age 0.026 0.003 0.349 8.007 0.000
Body mass index 0.065 0.016 0.178 4.089 0.000
TG Wrist circumference 0.046 0.008 0.269 6.010 0.000
Diastolic blood
pressure
0.015 0.005 0.136 3.054 0.002
Blood glucose 0.107 0.033 0.138 3.191 0.002
HDL-C Wrist circumference −0.009 0.004 −0.113 −2.445 0.015
LDL-C Cigarette smoking −0.559 0.232 −0.107 −2.410 0.016
Age 0.022 0.003 0.352 7.891 0.000
Wrist circumference 0.019 0.005 0.156 3.572 0.000
ApoAI Body mass index −0.008 0.004 −0.092 −2.009 0.045
Table 5 Correlative factors for serum lipid parameters
between males and females in both ethnic groups
(Continued)
Cigarette smoking 0.188 0.067 0.129 2.796 0.005
ApoB Wrist circumference 0.003 0.002 0.110 1.656 0.098
Blood glucose 0.018 0.005 0.149 3.399 0.001
Age 0.003 0.001 0.249 5.386 0.000
Body mass index 0.012 0.004 0.182 2.788 0.006
Cigarette smoking −0.135 0.050 −0.119 −2.681 0.008
ApoAI/B Body mass index −0.040 0.008 −0.232 −5.354 0.000
Age −0.009 0.002 −0.246 −5.511 0.000
Cigarette smoking 0.613 0.133 0.206 4.610 0.000
Mulao/male
TC Wrist circumference 0.022 0.007 0.192 3.314 0.001
TG Wrist circumference 0.067 0.011 0.341 6.201 0.000
Alcohol consumption 0.299 0.109 0.151 2.754 0.006
HDL-C Alcohol consumption 0.118 0.027 0.235 4.333 0.000
Wrist circumference −0.015 0.003 −0.297 −5.464 0.000
Age 0.005 0.002 0.151 2.787 0.006
LDL-C Body mass index 0.036 0.015 0.140 2.399 0.017
ApoAI Alcohol consumption 0.123 0.026 0.266 4.659 0.000
ApoB Wrist circumference 0.009 0.004 0.134 2.294 0.023
ApoAI/Apo B Alcohol consumption 0.162 0.041 0.222 3.959 0.000
Wrist circumference −0.017 0.004 −0.233 −4.150 0.000
Mulao/female
TC Age 0.015 0.004 0.190 3.897 0.000
Body mass index 0.056 0.019 0.146 2.985 0.003
TG Wrist circumference 0.029 0.007 0.209 4.311 0.000
Alcohol consumption 1.028 0.283 0.176 3.639 0.000
HDL-C Body mass index −0.034 0.007 −0.250 −5.150 0.000
LDL-C Body mass index 0.062 0.015 0.204 4.256 0.000
Age 0.014 0.003 0.220 4.584 0.000
ApoB Wrist circumference 0.014 0.003 0.221 4.553 0.000
Blood glucose 0.037 0.018 0.104 2.095 0.037
Age 0.003 0.002 0.100 2.027 0.043
ApoAI/Apo B Wrist circumference −0.019 0.005 −0.186 −3.820 0.000
Age −0.008 0.003 −0.150 −3.082 0.002
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein
cholesterol; LDL-C, low-density lipoprotein cholesterol; Apo AI, Apo lipoprotein
AI; Apo B, Apo lipoprotein B.
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http://www.lipidworld.com/content/11/1/61the subjects with GG and CG genotypes had higher
LDL-C, ApoB levels and lower the ratio of ApoAI to
ApoB than the subjects with CC genotype. When serum
lipid levels were analyzed according to sex, the G allele car-
riers in Han had higher serum TC, LDL-C and ApoB levels
in males and lower the ratio of ApoAI to ApoB in both
sexes than the G allele noncarriers. The G allele carriers in
Table 6 Interaction between rs2072183 SNP and several environmental factors on serum lipid phenotypes
Environmental factor F/P TC TG HDL-C LDL-C ApoAI ApoB ApoAI/ApoB
Han Chinese
Age F 1.685 0.768 1.830 0.492 1.730 0.867 1.410
P 0.099 0.631 0.068 0.862 0.088 0.544 0.189
Gender F 1.336 0.860 1.576 0.581 5.460 1.787 5.977
P 0.263 0.424 0.207 0.559 0.004 0.168 0.003
Body mass index F 2.406 4.276 4.111 3.110 2.370 6.915 6.440
P 0.091 0.014 0.017 0.045 0.094 0.001 0.002
Wrist circumference F 1.722 0.144 3.928 2.695 1.545 5.992 4.495
P 0.179 0.886 0.020 0.068 0.214 0.003 0.011
Systolic blood pressure F 0.637 0.016 0.927 1.194 0.107 0.337 0.496
P 0.529 0.940 0.396 0.304 0.899 0.714 0.609
Diastolic blood pressure F 2.618 0.268 0.297 5.737 0.238 3.047 1.409
P 0.074 0.765 0.743 0.003 0.789 0.048 0.245
Blood glucose F 0.549 0.038 0.120 4.463 0.048 1.396 1.682
P 0.578 0.963 0.887 0.012 0.954 0.248 0.187
Alcohol consumption F 4.880 2.770 0.157 1.135 2.142 2.066 1.004
P 0.001 0.026 0.960 0.339 0.074 0.084 0.404
Cigarette smoking F 1.864 2.810 1.422 2.229 0.460 0.276 0.053
P 0.115 0.025 0.225 0.064 0.765 0.893 0.995
Mulao
Age F 0.511 1.450 0.592 1.034 1.402 0.647 0.548
P 0.849 0.172 0.785 0.408 0.192 0.739 0.821
Gender F 3.461 0.283 7.360 1.681 0.021 1.019 0.084
P 0.032 0.753 0.001 0.187 0.979 0.362 0.919
Body mass index F 1.422 0.989 0.031 1.599 0.439 0.056 0.086
P 0.242 0.372 0.969 0.203 0.645 0.945 0.918
Wrist circumference F 1.656 2.006 0.231 0.606 0.465 0.132 0.049
P 0.192 0.135 0.794 0.546 0.628 0.876 0.952
Systolic blood pressure F 2.098 0.751 0.514 1.460 1.060 0.921 1.156
P 0.124 0.472 0.598 0.233 0.347 0.399 0.315
Diastolic blood pressure F 0.937 0.836 0.080 0.165 1.023 0.074 1.591
P 0.392 0.434 0.923 0.848 0.360 0.929 0.204
Blood glucose F 2.041 0.566 2.071 0.628 0.395 1.960 2.200
P 0.131 0.568 0.127 0.534 0.674 0.142 0.112
Alcohol consumption F 0.830 1.000 1.437 0.629 0.396 0.479 0.228
P 0.506 0.407 0.220 0.642 0.811 0.751 0.923
Cigarette smoking F 2.429 0.604 2.900 1.124 1.559 0.831 0.548
P 0.047 0.660 0.021 0.344 0.183 0.505 0.700
Environmental factors were scored as follow: BMI (≤ 24 kg/m2= 1, > 24 kg/m2 = 2); Wrist circumference (≤ 80 cm=1, > 80 cm=2); Systolic blood pressure
(< 140 mmHg= 1, ≥ 140 mmHg= 2); Diastolic blood pressure (< 90 mmHg= 1, ≥ 90 mmHg= 2); Blood glucose (≤ 6.1 mmol/L = 1, > 6.1 mmol/L = 2); Alcohol
consumption (nondrinker = 0, < 25 g/d = 1, ≥ 25 g/d = 2); Cigarette smoking (nonsmoker = 0, < 20 cigarettes/d = 1, ≥ 20 cigarettes/d = 2).
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http://www.lipidworld.com/content/11/1/61Mulao had higher serum TC and LDL-C levels in males
and lower HDL-C levels in both sexes than the G allele
noncarriers. The reason for these conflicting results is not
fully understood, probably because of differences in studydesigns, sample size, race, the methods used to determine
serum lipid levels and the effectiveness of this poly-
morphism or interaction with other SNPs, as well as
gene-environmental interactions.
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http://www.lipidworld.com/content/11/1/61In addition to genetic polymorphism, serum lipid levels in
our study populations were also affected by many environ-
mental factors. Multiple linear regression analysis showed that
serum lipid parameters were also affected by several environ-
mental factors such as age, gender, BMI, wrist circumference,
alcohol consumption, cigarette smoking, blood pressure and
blood glucose. Although rice and corn are the staple foods in
both ethnic groups, with the improvement of local living stan-
dards, the diet structure of Mulao has changed gradually. They
eat too many high-cholesterol foods such as fat, animal offal,
spinal cord and brain, which can directly raise blood
cholesterol concentrations. They also like to eat fried foods
containing a large number of trans-fatty acids which have
been consistently shown in multiple and rigorous randomized
trials to have adverse effects on blood lipids [49,50], thereby
increase the probability of suffering from coronary
heart disease [51-53]. In our study populations, the percen-
tages of subjects who consumed heavy alcohol were higher
in Mulao than in Han. It is well known that moder-
ate ethanol intake could increases the level of HDL-C and
decreased risk of CVD [54,55], but consumption of large
amounts of ethanol, or binge drinking would have the op-
posite result [56]. Alcohol consumption also has an
important influence on the level of LDL-C [57]. Perissinotto
et al. [57] reported that alcohol intake increase serum
LDL-C levels in older Italian subjects (65–84 years old).
Another recent study of Turks also found increases in
LDL-C, as well as in ApoB and TG, with alcohol in men,
while women had decreased TG and no change in LDL-C
or ApoB with alcohol [58]. In addition, a greater amount of
alcohol intake was also associated with higher values for
blood pressure [57,59], TG [58,60], HDL-C [55] and waist
circumference [60].
It is well known that interactions between genetic and en-
vironmental factors play an important role in determining
serum lipid levels [61,62]. In the present study, we detected
the potential interactions between rs2072183 SNP and
several environmental factors including age, gender, BMI,
wrist circumference, systolic blood pressure, diastolic blood
pressure, blood glucose, alcohol consumption, and cigarette
smoking on serum lipid phenotypes. The results showed
that the genotypes of rs2072183 SNP were interacted with
gender or cigarette smoking to influence serum TC and
HDL-C levels in Mulao, whereas the genotypes of
rs2072183 SNP were interacted with several environmental
factors to influence all seven lipid traits in Han. These
results suggest that some environmental factors in our
study populations might affect serum lipid levels directly
and/or indirectly by gene-environmental interactions.
Furthermore, the NPC1L1 gene-environmental interactions
on serum lipid levels were different between the two ethnic
groups. However, there are still many unmeasured environ-
mental and genetic factors and their interactions in the
present study. Thus, the interactions of environment-environment, environment-gene, and gene-gene on serum
lipid levels remain to be determined.
Conclusion
The present study shows that the association of NPC1L1
1735 C>G polymorphism and serum lipid levels is
different between the Mulao and Han populations. The dif-
ference in the association of NPC1L1 1735 C>G poly-
morphism and serum lipid levels between the two
ethnic groups might partly result from different
NPC1L1 1735 C>G polymorphism and/or NPC1L1
gene-environmental interactions.
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